EquityWireNifty 50 Earnings: Sun Pharma Q1 consolidated net profit falls nearly 20 per cent to INR 22.79 bln
Nifty 50 Earnings
Sun Pharma Q1 consolidated net profit falls nearly 20 per cent to INR 22.79 bln
This story was originally published at 14:34 IST on 31 July 2025
Register to read our real-time news.Informist, Thursday, Jul. 31, 2025
MUMBAI - Sun Pharmaceutical Industries Ltd.'s consolidated net profit for the June quarter fell almost 20% to INR 22.79 billion from INR 28.36 billion a year ago. The net profit was far lower than analysts' estimate of INR 29.62 billion. On the other hand, the company's consolidated revenue for the quarter rose 9.5% to INR 138.51 billion from INR 126.53 billion a year ago.
* Sun Pharma Apr-Jun consol net profit INR 22.79 bln vs INR 28.36 bln yr ago
* Analysts saw Sun Pharma Apr-Jun consol net profit at INR 29.62 bln
* Sun Pharma Apr-Jun consol revenue INR 138.51 bln vs INR 126.53 bln yr ago
* Sun Pharma Apr-Jun net profit includes one-time cost INR 8.18 bln
To read more please subscribe
Share this Story:
